CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
59 hedge funds and large institutions have $416M invested in Crescent Biopharma, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 15 reducing their positions, and 17 closing their positions.
Holders
59
Holders Change
-11
Holders Change %
-15.71%
% of All Funds
1.47%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
7
Increased
26
Reduced
15
Closed
17
Calls
–
Puts
$195K
Net Calls
-$195K
Net Calls Change
+$584K